Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Amphenol heads into its October 28 earnings report with a fresh vote of confidence from Goldman Sachs and a stock that has recovered 5% on the week, but the recent history of analyst target resets means the bullish framing deserves some scrutiny.
The most notable development this week came from Goldman Sachs analyst Mark Delaney, who raised his price target from $102 to $116 while maintaining a Buy rating, filed on October 6. That move follows Bernstein's initiation at Outperform with a $99 target on September 23 and BNP Paribas lifting its target to $110 from $107.50 a few days earlier. The direction from active analysts is constructive, with the consensus mean price target now at $101.29, implying roughly 14% upside from the current $88.62 close. That said, two earlier entries in the analyst register are worth a note of caution: TD Cowen cut its target to $90 from $175 on September 9, and Barclays adjusted from $200 to $100 on September 8. Both firms kept their ratings but halved their price targets, and both targets predate the stock's recent recovery. The UBS and BNP Paribas targets from late July, at $197 and $215 respectively, are also out of step with the current price by a wide enough margin to suggest they may not have been refreshed since the stock's steep year-to-date selloff. Readers should treat the mean target with that context in mind.
The borrow market offers no meaningful short-side story here. Short interest is just 2.6% of the free float, and while that figure has roughly doubled over the past month in percentage terms, the absolute level remains low. Availability is at its ceiling, with an enormous pool of shares available to lend and no signs of tightness. Cost to borrow has ticked up 35% on the week to 0.34%, but that still makes APH one of the cheapest names to short in the electronic components space. The ORTEX short score of 32.6 is in the bottom half of the universe and has been drifting gently lower all week, consistent with a stock where the bears have little structural conviction.
Options positioning is modestly defensive without being alarming. The put/call ratio is running at 1.23, fractionally above its 20-day average of 1.19 and only 0.3 standard deviations from the mean, well within normal range. Notably, the PCR touched 3.94 briefly in early September, so the current reading represents a significant easing of downside protection demand since that spike. The stock's factor profile reinforces the broadly benign setup: the analyst recommendation differential ranks in the 94th percentile, the dividend score is at the 98th percentile, and the EPS surprise rank is at the 71st percentile, all of which support the bull case of a quality compounder with consistent execution.
The bull-vs-bear debate on Amphenol centres on the pace and durability of its AI infrastructure and EV exposure versus the drag from softening industrial production and reduced automation spending. The company's connector business has material overlap with hyperscale data centre buildout, which the bull case projects driving close to 200% growth in its AI-related segment. The bear side flags supply chain constraints in automotive, uncertainty around acquisition pace, and any delay in hyperscale capital deployment as the primary risks. Valuation gives some ammunition to both camps: the P/E of 28x and EV/EBITDA of 16.7x are reasonable for the quality of the franchise but offer little margin of safety if industrial demand continues to soften into year-end.
The earnings history gives context on what the market has priced in. The July 29 Q2 print was the standout: the stock jumped 11% on the day and nearly 20% over the following five sessions, the kind of reaction that tends to rebuild confidence in a name that had been under pressure. The prior quarter's April print was more muted at 2.5% on the day before slipping 3.7% over five days. With Q3 due October 28, three weeks away, the setup is a stock that has clawed back some ground on the back of positive analyst commentary but still trades well below where most of the summer price targets were set.
Wikipedia attention data from Wikimedia Foundation shows retail interest in Amphenol running 1.4 standard deviations above its own 90-day average as of late September, a measure of elevated curiosity rather than a financial signal, but it suggests the stock's recovery has drawn broader notice.
The October 28 print is the key event to watch: whether management's commentary on AI connector demand and automotive channel inventory tracks what the Goldman and BNP upgrades have already assumed.
See the live data behind this article on ORTEX.
Open APH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
